<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30967127</article-id>
<article-id pub-id-type="pmc">6454596</article-id>
<article-id pub-id-type="publisher-id">772</article-id>
<article-id pub-id-type="doi">10.1186/s12881-019-0772-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exome-wide survey of the Siberian Caucasian population</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yurchenko</surname>
<given-names>Andrey A.</given-names>
</name>
<address>
<email>andreyurch@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yudin</surname>
<given-names>Nikolai S.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Voevoda</surname>
<given-names>Mikhail I.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2254 1834</institution-id><institution-id institution-id-type="GRID">grid.415877.8</institution-id><institution>The Federal Research Center Institute of Cytology and Genetics, </institution><institution>The Siberian Branch of the Russian Academy of Sciences, </institution></institution-wrap>Lavrentieva 10 St, Novosibirsk, Russia 630090 </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121896553</institution-id><institution-id institution-id-type="GRID">grid.4605.7</institution-id><institution>Novosibirsk State University, </institution></institution-wrap>Novosibirsk, 630090 Russia </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2254 1834</institution-id><institution-id institution-id-type="GRID">grid.415877.8</institution-id><institution>Institute of Internal and Preventive Medicine-branch of Institute of Cytology and Genetics, </institution><institution>Siberian Branch of Russian Academy of Sciences, </institution></institution-wrap>175/1, B. Bogatkov Street, 630089 Novosibirsk, Russia </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>9</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>Suppl 1</issue>
<issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.</issue-sponsor>
<elocation-id>51</elocation-id>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Population structure is an important factor in the genetic association studies but often remains underexplored for many human populations. We identified exome variants in 39 Siberian Caucasian individuals from Novosibirsk, Russia and compared their genetic allele frequencies with European populations from 1000 Genomes Project.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">The study participants were from Novosibirsk and represented people with monogenic diabetes, healthy individuals and a cohort from the tick-borne encephalitis study. Isolated DNA was enriched using Agilent SureSelect V5 kit and sequenced on Illumina HiSeq 4000 and genetic variants were identified using GATK pipeline. To estimate the patterns of the population structure we used PCA and ADMIXTURE analysis. Pharmocogenetically and medically important variants were annotated based on PharmGKB and ClinVar databases.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">The analysis identified low, but highly significant population differentiation attributed to numerous loci between the Siberian Caucasian population and other European population samples as well as a higher proportion of the Finnish genetic component in the studied sample. The medical and pharmacogenetic annotation of highly significantly differentiated variants between the Novosibirsk and the combined European populations revealed a number of important genetic polymorphisms located in such genes as <italic>FCGR3B</italic>, <italic>TYR</italic>, <italic>OCA2</italic>, <italic>FABP1</italic>, <italic>CHEK2</italic> and <italic>SLC4A1</italic>.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">The study reports for the first time an exome-wide comparison of a population from Russia with European samples and emphasizes the importance of population studies with medical annotation of variants.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Exome sequencing</kwd>
<kwd>Population structure</kwd>
<kwd>Associations</kwd>
<kwd>Siberia</kwd>
<kwd>Russia</kwd>
</kwd-group>
<conference xlink:href="http://conf.bionet.nsc.ru/bgrssb2018/en/">
<conf-name>11th International Multiconference “Bioinformatics of Genome Regulation and Structure\Systems Biology” - BGRS\SB-2018</conf-name>
<conf-loc>Novosibirsk, Russia</conf-loc>
<conf-date>20-25 August 2018</conf-date>
</conference>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par5">Population structure is a very important factor in medical genetic association studies which can compromise modern genomic methods not being properly accounted for. In Russia, population studies were mainly conducted using Y-chromosome or mitochondrial markers with the recent application of microarray methods [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>] and did not allow to estimate the functional role of variants. Some recent phylogeographic studies used whole-genome sequencing with samples from Russia to elucidate history of migrations in Eurasia, but used small samples from diverse populations [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. In this study, we identified exome genetic variants for 39 individuals from Novosibirsk, Russia and compared them with the previously published genome-wide data and exomes of European populations from the 1000 Genomes Project to understand the level of the exome-wide divergence and the extent of the population stratification. The Novosibirsk population (NVSB) is of particular interest because it exhibits an example of a modern big city population affected by political and economic events of the twentieth century which changed the historical landscape of ethnic diversity of the former USSR territory through increasing urbanization, mass migration across the country and rapid demographic growth. In this study, we identified exome genetic variants for 39 individuals from Novosibirsk, Russia and compared them with the previously published genome-wide data and exomes of European populations from the 1000 Genomes Project to understand the level of the exome-wide divergence and the extent of the population stratification. Additionally, we tested allele frequency differences between our sample and combined European dataset for medically and pharmacogenetically important variants to identify loci which can be important for national studies.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<p id="Par6">The study participants (<italic>n</italic> = 39) were from Novosibirsk and represented people with monogenic diabetes (<italic>n</italic> = 10), healthy individuals (<italic>n</italic> = 7) and a cohort from the tick-borne encephalitis study (<italic>n</italic> = 22). The participants signed an informed consent and defined themselves as ethnic Russians. The ethnicity of the participants was additionally checked prior the analysis with data from 1000 Genomes Project and two samples identified as clear outliers (close to the Asian populations) were excluded from the analysis. Isolated DNA was enriched using Agilent SureSelect V5 kit in and sequenced on Illumina HiSeq 4000 with 150PE reads. After the quality control with Trimmomatic [<xref ref-type="bibr" rid="CR6">6</xref>] the reads were aligned with BWA mem [<xref ref-type="bibr" rid="CR7">7</xref>] to Hg19 reference genome and processed with SAMtools [<xref ref-type="bibr" rid="CR8">8</xref>]. Single nucleotide variants (SNVs) and indels were identified using GATK [<xref ref-type="bibr" rid="CR9">9</xref>] according to the GATK Best Practices workflow for germline variation with the sensitivity filter equal to 99.9. The resulted VCF file was combined with 1000 Genomes Project genotypes [<xref ref-type="bibr" rid="CR10">10</xref>] using bcftools [<xref ref-type="bibr" rid="CR11">11</xref>] <italic>merge</italic> and filtered with VCFtools [<xref ref-type="bibr" rid="CR11">11</xref>] at maximum 10 missed genotypes (<italic>−-max-missing-count</italic>) keeping only biallelic sites.</p>
<p id="Par7">We performed the analysis on the two levels: with the Finnish (FIN) population for population genetic analysis (PCA, ADMIXTURE, Fst) and without FIN population to test the allele frequency differences for clinically and pharmacogenetically important variants. The FIN population was excluded from the second analysis as the most divergent European population with unique history [<xref ref-type="bibr" rid="CR12">12</xref>]. To reduce the influence of the tightly linked loci on the patterns of population structure we applied the linkage-disequilibrium pruning using PLINK V1.93 software (Table <xref ref-type="table" rid="Tab1">1</xref>). To estimate the patterns of the population structure we used the Principal Component Analysis (PCA) realised in SNPrelate [<xref ref-type="bibr" rid="CR13">13</xref>] with European (1000 Genomes Project) and previously published Russian Siberian populations [<xref ref-type="bibr" rid="CR2">2</xref>]. The proportions of genetic ancestry between populations were estimated using ADMIXTURE [<xref ref-type="bibr" rid="CR14">14</xref>] for K = 2–8 (Table <xref ref-type="table" rid="Tab1">1</xref>) and tested using Cross Validation Error estimation (CVE). To estimate and test statistically the level of pairwise population differentiation (Fst, [<xref ref-type="bibr" rid="CR15">15</xref>]) we used <italic>smartpca</italic> software of the EIGENSTRAT package [<xref ref-type="bibr" rid="CR16">16</xref>].<table-wrap id="Tab1"><label>Table 1</label><caption><p>Number of variants and filters applied to them for various analysis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Analysis</th><th>Number of variants</th><th>Filters</th></tr></thead><tbody><tr><td>PCA</td><td>5948</td><td>LD &lt; 0.3, only autosomes, MAF = 0.05, LD window = 100kbp</td></tr><tr><td>ADMIXTURE</td><td>55,669</td><td>LD &lt; 0.2, only autosomes, LD window = 50kbp</td></tr><tr><td>Fst (<italic>smartpca</italic>)</td><td>65,436</td><td>only autosomes, MAF = 0.05</td></tr><tr><td>Allele frequency difference</td><td>117,010 (SNV) 5989(INDEL)</td><td>PLINK: --assoc fisher-midp mperm = 1,000,000</td></tr></tbody></table></table-wrap></p>
<p id="Par8">We annotated the variants using ANNOVAR [<xref ref-type="bibr" rid="CR17">17</xref>] and PharmGKB [<xref ref-type="bibr" rid="CR18">18</xref>] databases and then tested medically (ClinVar, [<xref ref-type="bibr" rid="CR19">19</xref>]) and pharmacogenetically relevant variants for the differences in allele frequencies between the NVSB population and the combined non-Finnish European (NFE) dataset with PLINK v1.93 [<xref ref-type="bibr" rid="CR20">20</xref>] using 1 M permutations.</p>
<p id="Par9">The average coverage of the studied exomes varied from 47.7X to 71.3X. In total, we identified 136,276 SNVs and 14,464 indels in the studied dataset. Merging with data from 1000 Genomes Project produced a dataset of overlapped variants consisted of 117,010 SNVs and 5989 indels.</p>
</sec>
<sec id="Sec3">
<title>Results</title>
<p id="Par10">During the population genetic analysis, the first principal component accounted for 0.77% of the total variation and separated all the populations (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a) except closely related American (CEU) and British (GBR). The second principal component accounted for 0.36% of the total variation and separated mostly Tuscan (TSI) and Spanish (IBS) samples. Novosibirsk population (NVSB) was placed between the Finnish (FIN) and CEU with GBR samples and was clearly distinguished from them. The Russian Siberian populations from a previous microarray-based study [<xref ref-type="bibr" rid="CR2">2</xref>], represented by a similar Caucasian Siberian population (Russian_NSK) and partially isolated Siberian Starovers (Old Believers, Russian_STV) were not distinguished between each other and samples from our study (NVSB).<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> Principal Component Analysis (Russian_NSK and Russian_STV are Russian from Novosibirsk and Siberian starovers respectively from [<xref ref-type="bibr" rid="CR2">2</xref>]) <bold>b</bold> Observed and expected <italic>P</italic>-value distribution for allele frequency differences between NVSB and combined NFE sample <bold>c</bold> Results of the ADMIXTURE analysis for K = 2–5</p></caption><graphic id="MO1" xlink:href="12881_2019_772_Fig1_HTML"></graphic></fig></p>
<p id="Par11">In ADMIXTURE analysis, the lowest value of the Cross Validation Error was attributed to the K = 2, which captured the divergence of FIN from other European populations. NVSB demonstrated a higher proportion of the ancestral Finnish-related genetic component at K = 2 and at K = 3 relative to other populations. A new cluster (green) consisted of TSI and IBS appeared at K = 3 and then at an additional ancestral component emerged (K = 4) clearly separating NVSB (Fig. <xref ref-type="fig" rid="Fig1">1</xref>c, purple). Lastly, at K = 5, the IBS was separated from the rest of the samples.</p>
<p id="Par12">The pairwise Fst values between all the populations except the CEU and GBR (<italic>P</italic>-value = 0.048) were highly significant (<italic>P</italic>-value &lt; 1.1656e-11) albeit low (Fst = 0.002–0.013). The NVSB population demonstrated the highest level of differentiation with TSI (Fst = 0.009) and the lowest with GBR and CEU (Fst = 0.005). The results of the test for allele frequency differences between NVSB and NFE populations demonstrated pervasive inflation of the <italic>P</italic>-values attributed to numerous loci (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b).</p>
<p id="Par13">Among the 452 pharmocogenetically and 210 medically important variants we found 3 and 7 variants respectively (Table <xref ref-type="table" rid="Tab2">2</xref>) which showed significant allele frequency differences between the NVSB and NFE population after the multiple testing correction (BH adjusted <italic>P</italic>-value &lt; 0.05). The most significant differences in allele frequencies were attributed to such genes as <italic>FCGR3B</italic>, <italic>TYR</italic>, <italic>OCA2</italic>, <italic>FABP1</italic> and <italic>SLC4A1</italic> genes.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Genetic variants from PharmGKB (<italic>P</italic>-value &lt; 0.01) and ClinVar (BH adjusted <italic>P</italic>-value &lt; 0.05) databases which demonstrated highly significant differences in allele frequency between NVSB and NFE</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chr:Position</th><th>SNP ID</th><th>Reference allele/subsitution</th><th>Frequency in NVSB</th><th>Frequency in NFE</th><th><italic>P</italic>-Value</th><th>BH adjusted <italic>P</italic>-value</th><th>Gene</th><th>Drug (PharmGKB evidence level)/Clinvar annotation (number of reports)</th><th>Phenotype</th><th></th></tr></thead><tbody><tr><td>2:88424066</td><td>rs2241883</td><td>T/C</td><td>0.5513</td><td>0.3171</td><td>3.55E-05</td><td>0.016046</td><td>FABP1</td><td>fenofibrate (3)</td><td>Hypertriglyceridemia</td><td rowspan="12">PharmGKB variants</td></tr><tr><td>14:64700045</td><td>rs944050</td><td>T/C</td><td>0.141</td><td>0.03682</td><td>0.0002365</td><td>0.047987333</td><td>ESR2</td><td>gemcitabine (3)</td><td>Pancreatic Neoplasms</td></tr><tr><td>15:75129594</td><td>rs2290573</td><td>G/A</td><td>0.2949</td><td>0.5095</td><td>0.0003185</td><td>0.047987333</td><td>ULK3</td><td>imatinib (3)</td><td>Leukemia, Myelogenous, Chronic, BCR-ABL Positive</td></tr><tr><td>5:79950508</td><td>rs1105525</td><td>C/T</td><td>0.2949</td><td>0.1425</td><td>0.001166</td><td>0.131758</td><td>DHFR</td><td>methotrexate (3)</td><td>Precursor Cell Lymphoblastic Leukemia-Lymphoma</td></tr><tr><td>1:161479745</td><td>rs1801274</td><td>A/G</td><td>0.3205</td><td>0.5071</td><td>0.002335</td><td>0.211084</td><td>FCGR2A</td><td>trastuzumab (2B)</td><td>Breast Neoplasms</td></tr><tr><td>1:70904800</td><td>rs1021737</td><td>G/T</td><td>0.3974</td><td>0.247</td><td>0.005383</td><td>0.2702056</td><td>CTH</td><td>busulfan, cyclophosphamide (3)</td><td>Hemopoietic stem cell transplant</td></tr><tr><td>1:171076966</td><td>rs2266782</td><td>G/A</td><td>0.5256</td><td>0.3587</td><td>0.004475</td><td>0.2702056</td><td>FMO3</td><td>sulindac, itopride (3)</td><td>NA</td></tr><tr><td>1:230845794</td><td>rs699</td><td>A/G</td><td>0.5769</td><td>0.4097</td><td>0.005978</td><td>0.2702056</td><td>AGT</td><td>atenolol, irbesartan (3)</td><td>Hypertension</td></tr><tr><td>2:65296798</td><td>rs7572857</td><td>G/A</td><td>0.3077</td><td>0.1746</td><td>0.00565</td><td>0.2702056</td><td>CEP68</td><td>aspirin (3)</td><td>Asthma</td></tr><tr><td>11:126162843</td><td>rs8177374</td><td>C/T</td><td>0.07692</td><td>0.1983</td><td>0.00425</td><td>0.2702056</td><td>TIRAP</td><td>ustekinumab (3)</td><td>Psoriasis</td></tr><tr><td>3:113890815</td><td>rs6280</td><td>C/T</td><td>0.8077</td><td>0.6615</td><td>0.008071</td><td>0.307736667</td><td>DRD3</td><td>risperidone (3)</td><td>Autistic disorder</td></tr><tr><td>7:150696111</td><td>rs1799983</td><td>T/G</td><td>0.7821</td><td>0.6306</td><td>0.00817</td><td>0.307736667</td><td>NOS3</td><td>cyclophosphamide, doxorubicin, fluorouracil, methotrexate (3)</td><td>Breast Neoplasms</td></tr><tr><td>1:161599693</td><td>rs448740</td><td>T/C</td><td align="char" char=".">0.97436</td><td align="char" char=".">0.6627</td><td>1.00E-06</td><td align="char" char=".">0.00021</td><td>FCGR3B</td><td>Pathogenic (1)</td><td>Neutrophil-specific antigens na1/na2</td><td rowspan="7">ClinVar variants</td></tr><tr><td>11:89017961</td><td>rs1126809</td><td>G/A</td><td align="char" char=".">0.0641</td><td align="char" char=".">0.272</td><td>4.00E-06</td><td align="char" char=".">0.00042</td><td>TYR</td><td>Benign(2);Likely benign(1); Pathogenic(3); Uncertain significance(1)</td><td>Albinism, melanoma</td></tr><tr><td>15:28228553</td><td>rs74653330</td><td>C/T</td><td align="char" char=".">0.0641</td><td align="char" char=".">0.001188</td><td>9.00E-06</td><td align="char" char=".">0.00063</td><td>OCA2</td><td>Likely benign(2);Pathogenic(1); Uncertain significance(1)</td><td>Tyrosinase-positive oculocutaneous albinism</td></tr><tr><td>1:145507765</td><td>rs201779890</td><td>G/C</td><td align="char" char=".">0.05128</td><td align="char" char=".">0.001188</td><td>0.0001065</td><td align="char" char=".">0.0037275</td><td>RBM8A</td><td>Pathogenic/Likely pathogenic​</td><td>Radial aplasia-thrombocytopenia syndrome</td></tr><tr><td>17:42338993</td><td>rs45562031</td><td>C/T</td><td align="char" char=".">0.1154</td><td align="char" char=".">0.02138</td><td>8.30E-05</td><td align="char" char=".">0.0037275</td><td>SLC4A1</td><td>Likely benign(2);Likely pathogenic(1); Pathogenic(1); Uncertain significance(2)</td><td>Spherocytosis type 4</td></tr><tr><td>22:29121087</td><td>rs17879961</td><td>A/G</td><td align="char" char=".">0.05128</td><td align="char" char=".">0.001188</td><td>0.0001025</td><td align="char" char=".">0.0037275</td><td>CHEK2</td><td>Likely pathogenic(4);Pathogenic(7); Uncertain significance(2)</td><td>Cancer of multiple types, susceptibility</td></tr><tr><td>16:89986144</td><td>rs1805008</td><td>C/T</td><td align="char" char=".">0.1667</td><td align="char" char=".">0.06176</td><td>0.001211</td><td align="char" char=".">0.03633</td><td>MC1R</td><td>Likely benign(2);Pathogenic(1)</td><td>Skin conditions</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Discussion</title>
<p id="Par14">In this study, we used an exome-wide dataset for the first time to study the population structure of the Caucasian Siberian population from a big Russian city Novosibirsk. The exome-wide survey of the Novosibirsk population demonstrated its genetic congruence with the previously published Russian dataset including the partially isolated Siberian Starovers regardless of the dramatic migration and demographic changes of the previous century. The Caucasian Novosibirsk population is quite homogeneous (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a) and significantly differentiated from other European populations from 1000 Genomes Project demonstrating a relatively higher Finnish component which is presumably ancestral but not a result of recent migrations according to the ADMIXTURE results (Fig. <xref ref-type="fig" rid="Fig1">1</xref>c). This genetic differentiation although low in absolute Fst values should be taken into account during association studies. We identified 10 medically relevant SNVs with statistically significant allele differences between the NVSB and NFE populations including rs2241883 in<italic> FABP1</italic> gene previously associated with polycystic syndrome [<xref ref-type="bibr" rid="CR21">21</xref>] and toxicity of fenofibrate [<xref ref-type="bibr" rid="CR22">22</xref>], rs1801274 variant in <italic>FCGR2A</italic> gene shown to be important for the efficiency of trastuzumab in breast neoplasms [<xref ref-type="bibr" rid="CR23">23</xref>], the rare rs17879961 variant in <italic>CHEK2</italic> gene reliably associated with predisposition to breast and colorectal cancer [<xref ref-type="bibr" rid="CR24">24</xref>] and showed elevated frequency in NVSB. These variants should be studied in future on an expanded dataset with associated clinical data.</p>
</sec>
<sec id="Sec5">
<title>Conclusion</title>
<p id="Par15">The study reports for the first time an exome-wide comparison of a population from Russia with European samples and emphasizes the importance of population studies with medical annotation of variants.</p>
</sec>
</body>
<back>
<ack>
<p>We acknowledge A. Bielhin for English language editing of the manuscript.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par16">This study and publication costs are funded by the grant from the Russian Science Foundation (project no. 16–15-00127).</p>
</sec>
<sec id="FPar2" sec-type="data-availability">
<title>Availability of data and materials</title>
<p id="Par17">The dataset (individual genetic variants) analysed during the current study is available from the corresponding author on reasonable request following approval of the Institute of Cytology and Genetics (Siberian Branch, Russian Academy of Sciences) authorities and the Bioethics Committee.</p>
</sec>
<sec id="FPar3">
<title>About this supplement</title>
<p id="Par18">This article has been published as part of <italic>BMC Medical Genetics Volume 20 Supplement 1, 2019: Selected articles from BGRS\SB-2018: medical genetics.</italic> The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcmedgenet.biomedcentral.com/articles/supplements/volume-20-supplement-1">https://bmcmedgenet.biomedcentral.com/articles/supplements/volume-20-supplement-1</ext-link>.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>AY, NY and MV designed the study; AY performed data analysis; AY wrote the draft of the manuscript; all authors read, edited and approved the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar4">
<title>Ethics approval and consent to participate</title>
<p>This research was approved by the Bioethics Committee of the Federal Research Centre Institute of Cytology and Genetics (Siberian Branch, Russian Academy of Sciences). All the participants signed an informed consent.</p>
</sec>
<sec id="FPar5">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar6">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar7">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kushniarevich</surname>
<given-names>Alena</given-names>
</name>
<name>
<surname>Utevska</surname>
<given-names>Olga</given-names>
</name>
<name>
<surname>Chuhryaeva</surname>
<given-names>Marina</given-names>
</name>
<name>
<surname>Agdzhoyan</surname>
<given-names>Anastasia</given-names>
</name>
<name>
<surname>Dibirova</surname>
<given-names>Khadizhat</given-names>
</name>
<name>
<surname>Uktveryte</surname>
<given-names>Ingrida</given-names>
</name>
<name>
<surname>Möls</surname>
<given-names>Märt</given-names>
</name>
<name>
<surname>Mulahasanovic</surname>
<given-names>Lejla</given-names>
</name>
<name>
<surname>Pshenichnov</surname>
<given-names>Andrey</given-names>
</name>
<name>
<surname>Frolova</surname>
<given-names>Svetlana</given-names>
</name>
<name>
<surname>Shanko</surname>
<given-names>Andrey</given-names>
</name>
<name>
<surname>Metspalu</surname>
<given-names>Ene</given-names>
</name>
<name>
<surname>Reidla</surname>
<given-names>Maere</given-names>
</name>
<name>
<surname>Tambets</surname>
<given-names>Kristiina</given-names>
</name>
<name>
<surname>Tamm</surname>
<given-names>Erika</given-names>
</name>
<name>
<surname>Koshel</surname>
<given-names>Sergey</given-names>
</name>
<name>
<surname>Zaporozhchenko</surname>
<given-names>Valery</given-names>
</name>
<name>
<surname>Atramentova</surname>
<given-names>Lubov</given-names>
</name>
<name>
<surname>Kučinskas</surname>
<given-names>Vaidutis</given-names>
</name>
<name>
<surname>Davydenko</surname>
<given-names>Oleg</given-names>
</name>
<name>
<surname>Goncharova</surname>
<given-names>Olga</given-names>
</name>
<name>
<surname>Evseeva</surname>
<given-names>Irina</given-names>
</name>
<name>
<surname>Churnosov</surname>
<given-names>Michail</given-names>
</name>
<name>
<surname>Pocheshchova</surname>
<given-names>Elvira</given-names>
</name>
<name>
<surname>Yunusbayev</surname>
<given-names>Bayazit</given-names>
</name>
<name>
<surname>Khusnutdinova</surname>
<given-names>Elza</given-names>
</name>
<name>
<surname>Marjanović</surname>
<given-names>Damir</given-names>
</name>
<name>
<surname>Rudan</surname>
<given-names>Pavao</given-names>
</name>
<name>
<surname>Rootsi</surname>
<given-names>Siiri</given-names>
</name>
<name>
<surname>Yankovsky</surname>
<given-names>Nick</given-names>
</name>
<name>
<surname>Endicott</surname>
<given-names>Phillip</given-names>
</name>
<name>
<surname>Kassian</surname>
<given-names>Alexei</given-names>
</name>
<name>
<surname>Dybo</surname>
<given-names>Anna</given-names>
</name>
<name>
<surname>Tyler-Smith</surname>
<given-names>Chris</given-names>
</name>
<name>
<surname>Balanovska</surname>
<given-names>Elena</given-names>
</name>
<name>
<surname>Metspalu</surname>
<given-names>Mait</given-names>
</name>
<name>
<surname>Kivisild</surname>
<given-names>Toomas</given-names>
</name>
<name>
<surname>Villems</surname>
<given-names>Richard</given-names>
</name>
<name>
<surname>Balanovsky</surname>
<given-names>Oleg</given-names>
</name>
</person-group>
<article-title>Genetic Heritage of the Balto-Slavic Speaking Populations: A Synthesis of Autosomal, Mitochondrial and Y-Chromosomal Data</article-title>
<source/>PLOS ONE
          <year>2015</year>
<volume>10</volume>
<issue>9</issue>
<fpage>e0135820</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0135820</pub-id>
<pub-id pub-id-type="pmid">26332464</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">Triska P, Chekanov N, Stepanov V, Khusnutdinova EK, Kumar GPA, Akhmetova V, et al. Between Lake Baikal and the Baltic Sea: genomic history of the gateway to Europe. BMC Genet. 2017;18(S1). Available from: 10.1186/s12863-017-0578-3</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khrunin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Khokhrin</surname>
<given-names>DV</given-names>
</name>
<name>
<surname>Filippova</surname>
<given-names>IN</given-names>
</name>
<name>
<surname>Esko</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nelis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bebyakova</surname>
<given-names>NA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Genome-wide analysis of populations from European Russia reveals a new pole of genetic Diversity in northern Europe</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<issue>3</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0058552</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>EHM</given-names>
</name>
<name>
<surname>Khrunin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pushkarev</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Khokhrin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Verbenko</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Reconstructing genetic history of Siberian and northeastern European populations</article-title>
<source/>Genome Res
          <year>2016</year>
<volume>27</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1101/gr.202945.115</pub-id>
<pub-id pub-id-type="pmid">27965293</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mallick</surname>
<given-names>Swapan</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Heng</given-names>
</name>
<name>
<surname>Lipson</surname>
<given-names>Mark</given-names>
</name>
<name>
<surname>Mathieson</surname>
<given-names>Iain</given-names>
</name>
<name>
<surname>Gymrek</surname>
<given-names>Melissa</given-names>
</name>
<name>
<surname>Racimo</surname>
<given-names>Fernando</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Mengyao</given-names>
</name>
<name>
<surname>Chennagiri</surname>
<given-names>Niru</given-names>
</name>
<name>
<surname>Nordenfelt</surname>
<given-names>Susanne</given-names>
</name>
<name>
<surname>Tandon</surname>
<given-names>Arti</given-names>
</name>
<name>
<surname>Skoglund</surname>
<given-names>Pontus</given-names>
</name>
<name>
<surname>Lazaridis</surname>
<given-names>Iosif</given-names>
</name>
<name>
<surname>Sankararaman</surname>
<given-names>Sriram</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Qiaomei</given-names>
</name>
<name>
<surname>Rohland</surname>
<given-names>Nadin</given-names>
</name>
<name>
<surname>Renaud</surname>
<given-names>Gabriel</given-names>
</name>
<name>
<surname>Erlich</surname>
<given-names>Yaniv</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>Thomas</given-names>
</name>
<name>
<surname>Gallo</surname>
<given-names>Carla</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>Jeffrey P.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Yun S.</given-names>
</name>
<name>
<surname>Poletti</surname>
<given-names>Giovanni</given-names>
</name>
<name>
<surname>Balloux</surname>
<given-names>Francois</given-names>
</name>
<name>
<surname>van Driem</surname>
<given-names>George</given-names>
</name>
<name>
<surname>de Knijff</surname>
<given-names>Peter</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>Irene Gallego</given-names>
</name>
<name>
<surname>Jha</surname>
<given-names>Aashish R.</given-names>
</name>
<name>
<surname>Behar</surname>
<given-names>Doron M.</given-names>
</name>
<name>
<surname>Bravi</surname>
<given-names>Claudio M.</given-names>
</name>
<name>
<surname>Capelli</surname>
<given-names>Cristian</given-names>
</name>
<name>
<surname>Hervig</surname>
<given-names>Tor</given-names>
</name>
<name>
<surname>Moreno-Estrada</surname>
<given-names>Andres</given-names>
</name>
<name>
<surname>Posukh</surname>
<given-names>Olga L.</given-names>
</name>
<name>
<surname>Balanovska</surname>
<given-names>Elena</given-names>
</name>
<name>
<surname>Balanovsky</surname>
<given-names>Oleg</given-names>
</name>
<name>
<surname>Karachanak-Yankova</surname>
<given-names>Sena</given-names>
</name>
<name>
<surname>Sahakyan</surname>
<given-names>Hovhannes</given-names>
</name>
<name>
<surname>Toncheva</surname>
<given-names>Draga</given-names>
</name>
<name>
<surname>Yepiskoposyan</surname>
<given-names>Levon</given-names>
</name>
<name>
<surname>Tyler-Smith</surname>
<given-names>Chris</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>Yali</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>M. Syafiq</given-names>
</name>
<name>
<surname>Ruiz-Linares</surname>
<given-names>Andres</given-names>
</name>
<name>
<surname>Beall</surname>
<given-names>Cynthia M.</given-names>
</name>
<name>
<surname>Di Rienzo</surname>
<given-names>Anna</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>Choongwon</given-names>
</name>
<name>
<surname>Starikovskaya</surname>
<given-names>Elena B.</given-names>
</name>
<name>
<surname>Metspalu</surname>
<given-names>Ene</given-names>
</name>
<name>
<surname>Parik</surname>
<given-names>Jüri</given-names>
</name>
<name>
<surname>Villems</surname>
<given-names>Richard</given-names>
</name>
<name>
<surname>Henn</surname>
<given-names>Brenna M.</given-names>
</name>
<name>
<surname>Hodoglugil</surname>
<given-names>Ugur</given-names>
</name>
<name>
<surname>Mahley</surname>
<given-names>Robert</given-names>
</name>
<name>
<surname>Sajantila</surname>
<given-names>Antti</given-names>
</name>
<name>
<surname>Stamatoyannopoulos</surname>
<given-names>George</given-names>
</name>
<name>
<surname>Wee</surname>
<given-names>Joseph T. S.</given-names>
</name>
<name>
<surname>Khusainova</surname>
<given-names>Rita</given-names>
</name>
<name>
<surname>Khusnutdinova</surname>
<given-names>Elza</given-names>
</name>
<name>
<surname>Litvinov</surname>
<given-names>Sergey</given-names>
</name>
<name>
<surname>Ayodo</surname>
<given-names>George</given-names>
</name>
<name>
<surname>Comas</surname>
<given-names>David</given-names>
</name>
<name>
<surname>Hammer</surname>
<given-names>Michael F.</given-names>
</name>
<name>
<surname>Kivisild</surname>
<given-names>Toomas</given-names>
</name>
<name>
<surname>Klitz</surname>
<given-names>William</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>Cheryl A.</given-names>
</name>
<name>
<surname>Labuda</surname>
<given-names>Damian</given-names>
</name>
<name>
<surname>Bamshad</surname>
<given-names>Michael</given-names>
</name>
<name>
<surname>Jorde</surname>
<given-names>Lynn B.</given-names>
</name>
<name>
<surname>Tishkoff</surname>
<given-names>Sarah A.</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>W. Scott</given-names>
</name>
<name>
<surname>Metspalu</surname>
<given-names>Mait</given-names>
</name>
<name>
<surname>Dryomov</surname>
<given-names>Stanislav</given-names>
</name>
<name>
<surname>Sukernik</surname>
<given-names>Rem</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>Lalji</given-names>
</name>
<name>
<surname>Thangaraj</surname>
<given-names>Kumarasamy</given-names>
</name>
<name>
<surname>Pääbo</surname>
<given-names>Svante</given-names>
</name>
<name>
<surname>Kelso</surname>
<given-names>Janet</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>Nick</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>David</given-names>
</name>
</person-group>
<article-title>The Simons Genome Diversity Project: 300 genomes from 142 diverse populations</article-title>
<source/>Nature
          <year>2016</year>
<volume>538</volume>
<issue>7624</issue>
<fpage>201</fpage>
<lpage>206</lpage>
<pub-id pub-id-type="doi">10.1038/nature18964</pub-id>
<pub-id pub-id-type="pmid">27654912</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolger</surname>
<given-names>Anthony M.</given-names>
</name>
<name>
<surname>Lohse</surname>
<given-names>Marc</given-names>
</name>
<name>
<surname>Usadel</surname>
<given-names>Bjoern</given-names>
</name>
</person-group>
<article-title>Trimmomatic: a flexible trimmer for Illumina sequence data</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<issue>15</issue>
<fpage>2114</fpage>
<lpage>2120</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id>
<pub-id pub-id-type="pmid">24695404</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<issue>14</issue>
<fpage>1754</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Wysoker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Homer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Marth</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The Sequence Alignment/Map format and SAMtools</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<issue>16</issue>
<fpage>2078</fpage>
<lpage>2079</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
<pub-id pub-id-type="pmid">19505943</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cibulskis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kernytsky</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gabriel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DePristo</surname>
<given-names>M. A.</given-names>
</name>
</person-group>
<article-title>The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Research
          <year>2010</year>
<volume>20</volume>
<issue>9</issue>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<mixed-citation publication-type="other">An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56–65. Available from: 10.1038/nature11632</mixed-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Danecek</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Auton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abecasis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Albers</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>DePristo</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Handsaker</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Lunter</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Marth</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Sherry</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>McVean</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The variant call format and VCFtools</article-title>
<source/>Bioinformatics
          <year>2011</year>
<volume>27</volume>
<issue>15</issue>
<fpage>2156</fpage>
<lpage>2158</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id>
<pub-id pub-id-type="pmid">21653522</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kääriäinen</surname>
<given-names>Helena</given-names>
</name>
<name>
<surname>Muilu</surname>
<given-names>Juha</given-names>
</name>
<name>
<surname>Perola</surname>
<given-names>Markus</given-names>
</name>
<name>
<surname>Kristiansson</surname>
<given-names>Kati</given-names>
</name>
</person-group>
<article-title>Genetics in an isolated population like Finland: a different basis for genomic medicine?</article-title>
<source/>Journal of Community Genetics
          <year>2017</year>
<volume>8</volume>
<issue>4</issue>
<fpage>319</fpage>
<lpage>326</lpage>
<pub-id pub-id-type="doi">10.1007/s12687-017-0318-4</pub-id>
<pub-id pub-id-type="pmid">28730583</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gogarten</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Laurie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weir</surname>
<given-names>B. S.</given-names>
</name>
</person-group>
<article-title>A high-performance computing toolset for relatedness and principal component analysis of SNP data</article-title>
<source/>Bioinformatics
          <year>2012</year>
<volume>28</volume>
<issue>24</issue>
<fpage>3326</fpage>
<lpage>3328</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/bts606</pub-id>
<pub-id pub-id-type="pmid">23060615</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alexander</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Novembre</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lange</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Fast model-based estimation of ancestry in unrelated individuals</article-title>
<source/>Genome Research
          <year>2009</year>
<volume>19</volume>
<issue>9</issue>
<fpage>1655</fpage>
<lpage>1664</lpage>
<pub-id pub-id-type="doi">10.1101/gr.094052.109</pub-id>
<pub-id pub-id-type="pmid">19648217</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hudson</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Slatkin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Maddison</surname>
<given-names>WP</given-names>
</name>
</person-group>
<article-title>Estimation of levels of gene flow from DNA sequence data</article-title>
<source/>Genetics
          <year>1992</year>
<volume>132</volume>
<issue>2</issue>
<fpage>583 LP</fpage>
<lpage>583589</lpage>
<pub-id pub-id-type="pmid">1427045</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Price</surname>
<given-names>Alkes L</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>Nick J</given-names>
</name>
<name>
<surname>Plenge</surname>
<given-names>Robert M</given-names>
</name>
<name>
<surname>Weinblatt</surname>
<given-names>Michael E</given-names>
</name>
<name>
<surname>Shadick</surname>
<given-names>Nancy A</given-names>
</name>
<name>
<surname>Reich</surname>
<given-names>David</given-names>
</name>
</person-group>
<article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>
<source/>Nature Genetics
          <year>2006</year>
<volume>38</volume>
<issue>8</issue>
<fpage>904</fpage>
<lpage>909</lpage>
<pub-id pub-id-type="doi">10.1038/ng1847</pub-id>
<pub-id pub-id-type="pmid">16862161</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>
<source/>Nucleic Acids Research
          <year>2010</year>
<volume>38</volume>
<issue>16</issue>
<fpage>e164</fpage>
<lpage>e164</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>
<pub-id pub-id-type="pmid">20601685</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hewett</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>PharmGKB: the Pharmacogenetics Knowledge Base</article-title>
<source/>Nucleic Acids Research
          <year>2002</year>
<volume>30</volume>
<issue>1</issue>
<fpage>163</fpage>
<lpage>165</lpage>
<pub-id pub-id-type="doi">10.1093/nar/30.1.163</pub-id>
<pub-id pub-id-type="pmid">11752281</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landrum</surname>
<given-names>Melissa J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Jennifer M.</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>George R.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>Wonhee</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>Wendy S.</given-names>
</name>
<name>
<surname>Church</surname>
<given-names>Deanna M.</given-names>
</name>
<name>
<surname>Maglott</surname>
<given-names>Donna R.</given-names>
</name>
</person-group>
<article-title>ClinVar: public archive of relationships among sequence variation and human phenotype</article-title>
<source/>Nucleic Acids Research
          <year>2013</year>
<volume>42</volume>
<issue>D1</issue>
<fpage>D980</fpage>
<lpage>D985</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>
<pub-id pub-id-type="pmid">24234437</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purcell</surname>
<given-names>Shaun</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>Benjamin</given-names>
</name>
<name>
<surname>Todd-Brown</surname>
<given-names>Kathe</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>Lori</given-names>
</name>
<name>
<surname>Ferreira</surname>
<given-names>Manuel A.R.</given-names>
</name>
<name>
<surname>Bender</surname>
<given-names>David</given-names>
</name>
<name>
<surname>Maller</surname>
<given-names>Julian</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>Pamela</given-names>
</name>
<name>
<surname>de Bakker</surname>
<given-names>Paul I.W.</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>Mark J.</given-names>
</name>
<name>
<surname>Sham</surname>
<given-names>Pak C.</given-names>
</name>
</person-group>
<article-title>PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses</article-title>
<source/>The American Journal of Human Genetics
          <year>2007</year>
<volume>81</volume>
<issue>3</issue>
<fpage>559</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1086/519795</pub-id>
<pub-id pub-id-type="pmid">17701901</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>Hongxi</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Han</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Xin</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Yue-ran</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Zi-Jiang</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Jinlong</given-names>
</name>
</person-group>
<article-title>Association of single-nucleotide polymorphisms rs2197076 and rs2241883 of FABP1 gene with polycystic ovary syndrome</article-title>
<source/>Journal of Assisted Reproduction and Genetics
          <year>2015</year>
<volume>33</volume>
<issue>1</issue>
<fpage>75</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1007/s10815-015-0626-8</pub-id>
<pub-id pub-id-type="pmid">26650609</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<mixed-citation publication-type="other">Brouillette C, Bossé Y, Pérusse L, Gaudet D, Vohl M-C. Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofibrate. J Hum Genet. 2004;49(8). Available from: 10.1007/s10038-004-0171-2</mixed-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shimizu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hojo</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akashi-Tanaka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yonemori</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kouno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Katsumata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aogi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Koizumi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nishio</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Fc R2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer</article-title>
<source/>Annals of Oncology
          <year>2010</year>
<volume>22</volume>
<issue>6</issue>
<fpage>1302</fpage>
<lpage>1307</lpage>
<pub-id pub-id-type="doi">10.1093/annonc/mdq585</pub-id>
<pub-id pub-id-type="pmid">21109570</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>Fei-fei</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Chang-long</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Li-hong</given-names>
</name>
</person-group>
<article-title>The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis</article-title>
<source/>DNA and Cell Biology
          <year>2013</year>
<volume>32</volume>
<issue>6</issue>
<fpage>329</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1089/dna.2013.1970</pub-id>
<pub-id pub-id-type="pmid">23713947</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>